Anthony W Burgess

Title: Anthony W. Burgess: Innovator in Cancer Research

Introduction

Anthony W. Burgess is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 2 patents, Burgess has focused on developing solutions that target colon cancer.

Latest Patents

Burgess's latest patents include an isolated protein that binds to the A33 antibody and peptides corresponding to it. This invention relates to isolated proteins and peptides found on the surface of colon cells and colon cancer cells. The protein and peptides bind to tumor-associated antibodies, such as mAb A33. The monomeric protein has a molecular weight of about 43 kD, as determined by SDS gel electrophoresis under non-reducing conditions. Additionally, this invention encompasses the use of nucleic acid molecules and antibodies specific for the protein and peptides in diagnostic, screening, and therapeutic methods. Another significant patent describes a colonic crypt cell stimulating mitogen and the conditioned medium containing it. This invention details a cell line, LIM 2537, which, when cultivated in medium, secretes a mitogen that stimulates the proliferation of colonic crypt cells.

Career Highlights

Burgess is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research and innovations. His work has been instrumental in understanding and developing treatments for colon cancer.

Collaborations

Burgess has collaborated with esteemed colleagues, including Lloyd J. Old and Sydney Welt, further enhancing the impact of his research in the scientific community.

Conclusion

Anthony W. Burgess is a prominent figure in cancer research, with innovative patents that contribute to the understanding and treatment of colon cancer. His work continues to inspire advancements in medical science.